CD274 and melanoma: Based on our findings, we recommend using PD-L1, expressed in tumor tissue, as a prognostic marker in cases of malignant melanoma, with a high PD-L1 staining score in the tumor indicating a poor prognosis and determining the indications for the patient’s clinical management and immunotherapy.